These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints. Sertdemir Y; Burgut R Contemp Clin Trials; 2009 Jan; 30(1):8-12. PubMed ID: 18809512 [TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of ICH E9. Brown D; Day S; Hemmings R; Wright D Pharm Stat; 2008; 7(2):77-87. PubMed ID: 18438957 [TBL] [Abstract][Full Text] [Related]
8. Clinical trials with allergen products--statistical considerations. Volkers P Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):172-80; discussion 181. PubMed ID: 17393737 [No Abstract] [Full Text] [Related]
9. Design and endpoints of clinical trials in hepatocellular carcinoma. Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ; J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802 [TBL] [Abstract][Full Text] [Related]
10. A new 'mechanistic-practical" framework for designing and interpreting randomized trials. Karanicolas PJ; Montori VM; Devereaux PJ; Schünemann H; Guyatt GH J Clin Epidemiol; 2009 May; 62(5):479-84. PubMed ID: 18468856 [TBL] [Abstract][Full Text] [Related]
11. Proceedings of the Symposium on Designs for Clinical Cancer Reseach. Discussion I: Basic design considerations. Cancer Treat Rep; 1980; 64(2-3):411-7. PubMed ID: 7407778 [No Abstract] [Full Text] [Related]
12. Proceedings of the Symposium on Designs for Clinical Cancer Research. Perspective of the clinician. Hoogstraten B Cancer Treat Rep; 1980; 64(2-3):537-8. PubMed ID: 7407796 [No Abstract] [Full Text] [Related]
13. [Decision making in clinical research: a statistical approach]. Lacaine F; Huguier M Gastroenterol Clin Biol; 1980 Nov; 4(11):754-7. PubMed ID: 7461386 [No Abstract] [Full Text] [Related]
15. [Methodological and statistical aspects of equivalence and non inferiority trials]. Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the statistical power for multiple tests: a case study. Yeo A; Qu Y Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588 [TBL] [Abstract][Full Text] [Related]
17. Statistical methods in clinical trials. Gebski VJ; Keech AC Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749 [No Abstract] [Full Text] [Related]
18. [Quality of clinical information (II): Statistical significance]. Plasencia A; Porta Serra M Med Clin (Barc); 1988 Jan; 90(3):122-6. PubMed ID: 3280891 [No Abstract] [Full Text] [Related]
19. The clinical significance of statistical significance. Kane RC Oncologist; 2008 Nov; 13(11):1129-33. PubMed ID: 18984874 [TBL] [Abstract][Full Text] [Related]
20. [From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology]. Cachin Y; Flamant R; Richard J; Sancho-Garnier H Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):47-52. PubMed ID: 7103330 [No Abstract] [Full Text] [Related] [Next] [New Search]